Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3532 studies found for:    vaccine clinical trials
Show Display Options
Rank Status Study
1 Completed Anthrax Vaccine Clinical Trials
Condition: Anthrax
Interventions: Drug: Anthrax Vaccine;   Procedure: Blood Chemistry;   Procedure: Hematology;   Procedure: Urinalysis
2 Completed Preventative Misconception Intervention
Conditions: HIV;   HIV Infections
Interventions: Behavioral: 1-sided messages;   Behavioral: 2-sided messages
3 Completed Evaluating the Safety and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults Who Have Participated in Previous HIV Vaccine Clinical Trials and in Adults Who Have Not Participated in Previous HIV Vaccine Clinical Trials
Condition: HIV Infections
Interventions: Biological: Sub C gp140 Vaccine;   Biological: MF59C.1 Adjuvant
4 Completed
Has Results
HIV Testing & Womens Attitudes on HIV Vaccine Trials
Condition: HIV
Intervention: Behavioral: Message Sidedness
5 Completed CDC Anthrax Vaccine Clinical Trial
Condition: Healthy
Intervention: Biological: BioThrax or Anthrax Vaccine Adsorbed
6 Completed Hepatitis B Vaccine Clinical Trial
Conditions: Hepatitis B;   Hepatitis, Viral, Human;   Liver Diseases
Intervention: Biological: hepatitis B vaccines
7 Completed Seasonal Trivalent Inactivated Split Virion Influenza Vaccine Clinical Trial (IVACFLU-S)
Condition: Influenza, Human
Interventions: Biological: Trivalent Seasonal Influenza Vaccine;   Biological: Placebo Comparator
8 Completed Influenza A/H5N1 Vaccine Clinical Trial (IVACFLU-A/H5N1) - Phase 1
Condition: Influenza A Subtype H5N1 Infection
Interventions: Biological: IVACFLU-A/H5N1, 7.5 mcg;   Biological: IVACFLU-A/H5N1, 15 mcg;   Biological: Placebo Comparator
9 Active, not recruiting Clinical Trial of Ebola Vaccines cAd3-EBO, cAd3-EBOZ and MVA-EbolaZ in Healthy Adults in Uganda
Condition: Hemorrhagic Fever, Ebola
Interventions: Biological: cAd3-EBOZ;   Biological: cAd3-EBO;   Biological: MVA-EbolaZ
10 Recruiting Screening Volunteers for Clinical Trials
Condition: Human Health
Intervention:
11 Recruiting A Laboratory Evaluation of the Humoral Immune Response in Adults and Children to the H1 Hemagglutinin (HA) Stalk Domain and Other Influenza A Virus Protein Epitopes, After Administration of GlaxoSmithKline (GSK) Biologicals' Pandemic Influenza Vaccines
Condition: Immunologic Tests
Intervention: Other: Serum samples
12 Unknown  Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1-infected Mothers
Conditions: HIV-1;   HIV Infections
Intervention: Biological: MVA.HIVA
13 Completed A Phase I Clinical Trial to Evaluate the Ebola Adenovirus Vector Vaccine (Ad5-EBOV) in Healthy Adults.
Condition: Ebola Virus Disease
Interventions: Biological: Low dose Ebola Zaire vaccine (Ad5-EBOV);   Biological: High dose Ebola Zaire vaccine (Ad5-EBOV);   Biological: placebo (one dose);   Biological: placebo (two doses)
14 Completed A Booster Dose of Ad5-EBOV in Healthy Adults After Primary Immunization
Condition: Ebola Virus Disease
Interventions: Biological: 4×10^10vp/1ml Ebola Zaire vaccine (Ad5-EBOV);   Biological: 1.6×10^11vp/2ml Ebola Zaire vaccine (Ad5-EBOV);   Biological: placebo
15 Completed Safety of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Children
Condition: Healthy
Intervention: Biological: 0.5ml/dose for a person
16 Completed Autologous Vaccine for Follicular Lymphoma
Condition: Lymphoma, Follicular
Intervention: Biological: Autologous FL vaccine
17 Recruiting Screening of Volunteers for Clinical Trials of Investigational or Licensed Vaccines or Antiviral Products
Condition: Healthy Volunteers
Intervention:
18 Active, not recruiting Field Trial of Maternal Influenza Immunization in Asia
Condition: Influenza Human
Interventions: Biological: influenza vaccine;   Biological: saline placebo
19 Completed A Clinical Trial of Split-virion Influenza A/H1N1 Vaccines
Condition: Influenza
Intervention: Biological: H1N1 influenza A Vaccine (Split virion), Inactivated
20 Completed Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 003
Condition: Meningitis
Interventions: Biological: ACYW135 Meningococcal Polysaccharide Vaccine;   Biological: A+C Meningococcal Polysaccharide Vaccine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.